AAAAAA

   
Results: 1-20 |
Results: 20

Authors: JENSEN PD OLSEN N BAGGER JP JENSEN FT CHRISTENSEN T ELLEGAARD J
Citation: Pd. Jensen et al., CARDIAC-FUNCTION DURING IRON CHELATION-THERAPY IN ADULT NON-THALASSEMIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD, European journal of haematology, 59(4), 1997, pp. 221-230

Authors: BERGMANN OJ MOGENSEN SC ELLERMANNERIKSEN S ELLEGAARD J
Citation: Oj. Bergmann et al., ACYCLOVIR PROPHYLAXIS AND FEVER DURING REMISSION-INDUCTION THERAPY OFPATIENTS WITH ACUTE MYELOID-LEUKEMIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Journal of clinical oncology, 15(6), 1997, pp. 2269-2274

Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E BIRGENS HS DRIVSHOLM A ELLEGAARD J LARSEN JK PLESNER T BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1011-1023

Authors: GEISLER CH HANSEN MM PHILIP P CHRISTENSEN BE HOUJENSEN K TINGGAARDPEDERSEN N JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H NIELSEN JB ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK
Citation: Ch. Geisler et al., IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE, Blood, 90(10), 1997, pp. 2358-2358

Authors: JENSEN PD HEICKENDORFF L HELWEGLARSEN HM JENSEN FT CHRISTENSEN T ELLEGAARD J
Citation: Pd. Jensen et al., SERUM PROCOLLAGEN-III PEPTIDE CONCENTRATION IN IRON OVERLOAD, European journal of haematology, 57(2), 1996, pp. 157-164

Authors: JENSEN PD HEICKENDORFF L PEDERSEN B BENDIXHANSEN K JENSEN FT CHRISTENSEN T BOESEN AM ELLEGAARD J
Citation: Pd. Jensen et al., THE EFFECT OF IRON CHELATION ON HEMATOPOIESIS IN MDS PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD, British Journal of Haematology, 94(2), 1996, pp. 288-299

Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS, Blood, 88(10), 1996, pp. 937-937

Authors: DYBKAER K ELLEGAARD J PEDERSEN B KRISTENSEN JS
Citation: K. Dybkaer et al., CLINICAL AND BIOLOGICAL ASPECTS OF MYELOID SURFACE-ANTIGEN EXPRESSIONIN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Tissue antigens, 48(4-II), 1996, pp. 611-611

Authors: BERGMANN OJ ELLERMANNERIKSEN S MOGENSEN SC ELLEGAARD J
Citation: Oj. Bergmann et al., ACYCLOVIR GIVEN AS PROPHYLAXIS AGAINST ORAL ULCERS IN ACUTE MYELOID-LEUKEMIA - RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, BMJ. British medical journal, 310(6988), 1995, pp. 1169-1172

Authors: JENSEN PD JENSEN FT CHRISTENSEN T ELLEGAARD J
Citation: Pd. Jensen et al., EVALUATION OF TRANSFUSIONAL IRON OVERLOAD BEFORE AND DURING IRON CHELATION BY MAGNETIC-RESONANCE-IMAGING OF THE LIVER AND DETERMINATION OF SERUM FERRITIN IN ADULT NON-THALASSEMIC PATIENTS, British Journal of Haematology, 89(4), 1995, pp. 880-889

Authors: MADSEN PS HOKLAND P CLAUSEN N ELLEGAARD J HOKLAND M
Citation: Ps. Madsen et al., DIFFERENTIAL EXPRESSION LEVELS OF THE HEAT-SHOCK PROTEIN-27 ISOFORMS IN PEDIATRIC NORMAL, NONLEUKEMIC AND COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA B-CELL PRECURSORS, Blood, 85(2), 1995, pp. 510-521

Authors: PEDERSEN B ELLEGAARD J
Citation: B. Pedersen et J. Ellegaard, A FACTOR ENCODED BY 7Q31 SUPPRESSES EXPANSION OF THE 7Q- CLONE AND DELAYS CYTOGENETIC PROGRESSION, Cancer genetics and cytogenetics, 78(2), 1994, pp. 181-188

Authors: JENSEN PD PETERSLUND NA POULSEN JH JENSEN FT CHRISTENSEN T ELLEGAARD J
Citation: Pd. Jensen et al., THE EFFECT OF IRON OVERLOAD AND IRON REDUCTIVE TREATMENT ON THE SERUMCONCENTRATION OF CARBOHYDRATE-DEFICIENT TRANSFERRIN, British Journal of Haematology, 88(1), 1994, pp. 56-63

Authors: JENSEN PD JENSEN FT ELLEGAARD J
Citation: Pd. Jensen et al., NONINVASIVE ASSESSMENT OF TISSUE IRON OVERLOAD IN THE LIVER BY MAGNETIC-RESONANCE-IMAGING, British Journal of Haematology, 87(1), 1994, pp. 171-184

Authors: JENSEN IM KRISTENSEN JS THOMSEN M ELLEGAARD J HOKLAND P
Citation: Im. Jensen et al., OPTIMIZATION OF A METHOD FOR SIMULTANEOUS ANALYSIS OF CELL-SURFACE PHENOTYPE AND CELL-CYCLE IN HUMAN BONE-MARROW AND PERIPHERAL-BLOOD LEUKOCYTES BY FLOW-CYTOMETRY - THE VALUE OF BOTH INTERNAL AND EXTERNAL STANDARDS, Analytical cellular pathology, 5(4), 1993, pp. 213-223

Authors: JENSEN PD BAGGER JP BAANDRUP U CHRISTENSEN T ELLEGAARD J JENSEN FT
Citation: Pd. Jensen et al., HEART-TRANSPLANTATION IN A CASE OF JUVENILE HEREDITARY HEMOCHROMATOSIS FOLLOWED UP BY MRI AND ENDOMYOCARDIAL BIOPSIES, European journal of haematology, 51(4), 1993, pp. 199-205

Authors: KELDSEN N BJERRUM OW DAHL IMS DRIVSHOLM A ELLEGAARD J GADEBERG O GIMSING P GRONVOLD T HANSEN MM HIPPE E LAMVIK J LY B SKARBOVIK A TALSTAD I THORLING K WESENBERG K WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85

Authors: JENSEN IM ELLEGAARD J HOKLAND P
Citation: Im. Jensen et al., DIFFERENCES IN RELATIVE DNA CONTENT BETWEEN HUMAN PERIPHERAL-BLOOD AND BONE-MARROW SUBPOPULATIONS - CONSEQUENCES FOR DNA INDEX CALCULATIONS, Cytometry, 14(8), 1993, pp. 936-942

Authors: NORGAARD JM LANGKJER ST ELLEGAARD J PALSHOF T CLAUSEN N HOKLAND P
Citation: Jm. Norgaard et al., SYNERGISTIC AND ANTAGONISTIC EFFECTS OF MYELOID GROWTH-FACTORS ON IN-VITRO CELLULAR KILLING BY CYTOTOXIC DRUGS, Leukemia research, 17(8), 1993, pp. 689-694

Authors: KRISTENSEN J KILLANDER A HIPPE E ELLEGAARD J HEDNER U
Citation: J. Kristensen et al., RECOMBINANT FACTOR-VIIA (RFVIIA) REDUCES THE BLEEDING-TIME IN PATIENTS WITH THROMBOCYTOPENIA, Blood, 82(10), 1993, pp. 10000155-10000155
Risultati: 1-20 |